Empagliflozin Initiation in Hospital Benefits both new onset and acute decompensated HF Patients: Study Written By Jacinthlyn Sylvia17 March 2026 9:15 AM ISTA new study published in the journal of JACC: Heart Failure showed that despite a decreased diuretic response in patients with acute decompensated...
Sacubitril/Valsartan Safe to Continue Even with GFR Below 30 ml/min in HF Patients: Research Finds Written By Dr. Garima Soni28 Oct 2024 10:57 AM ISTUSA: Recent research indicates that sacubitril/valsartan can be safely continued in heart failure patients, maintaining cardiovascular and kidney...
Vericiguat Lowers Cardiovascular Death Risk in Heart Failure Patients, Independent of Diabetes: VICTORIA Trial Analysis Written By Medha Baranwal24 Oct 2024 9:00 AM ISTUSA: The recent analysis from the VICTORIA trial has highlighted the potential benefits of vericiguat in managing cardiovascular (CV) outcomes for...
Subcutaneous Furosemide May Offer Effective Home-Based Treatment for Heart Failure, suggests new Pilot Study Written By Medha Baranwal21 Sept 2024 9:00 AM ISTUSA: Results from the AT HOME-HF pilot study have shown that subcutaneous (SC) furosemide, an innovative method of diuretic therapy administration,...
Furosemide Plus Metolazone Boosts Natriuresis in Ambulatory Chronic Heart Failure Patients, finds study Written By Medha Baranwal17 July 2024 9:15 AM ISTIsrael: Furosemide plus metolazone led to significantly higher natriuresis than IV furosemide alone or furosemide plus acetazolamide in ambulatory...
Sotagliflozin Cost-Effective for Heart Failure and Diabetes Patients, finds JACC Study Written By Jacinthlyn Sylvia28 Jun 2024 9:00 AM ISTA recent analysis of the SOLOIST-WHF trial published in the JACC: Heart Failure provided strong evidence on the cost-effectiveness of sotagliflozin...
HDL Parameters linked to Heart Failure Risk: Insights from Multicohort Analysis Written By Medha Baranwal30 May 2024 9:45 AM ISTUSA: Recent findings from a multicohort analysis have shed new light on the relationship between high-density lipoprotein (HDL) parameters and the...
IV furosemide and metolazone lead to higher natriuresis in ambulatory chronic heart failure patients: JACC Written By Medha Baranwal23 May 2024 10:00 AM ISTIsrael: A recent study, DEA-HF, has provided valuable insights into the efficacy of different diuretic regimens for managing congestion in ambulatory...
In HF patients, intravenous iron reduces both CV death and HF-related events Written By Jacinthlyn Sylvia17 Jan 2024 10:00 AM ISTA recent study published in the JACC: Heart Failure analyzed the guidelines that advocate the consideration of intravenous iron to reduce heart...
Empagliflozin reduces HF hospitalization and CV death regardless of baseline diuretic doses Written By Dr. Shravani Dali18 Sept 2023 12:00 PM ISTEmpagliflozin reduces HF hospitalization and CV death regardless of baseline diuretic doses suggests a new study published in the JACC: Heart...
Subclinical heart failure detected in three-quarters of patients of AF patients undergoing ablation: JACC Written By Medha Baranwal15 Sept 2023 9:30 AM ISTAustralia: A study conducted in Australia has revealed that nearly 75% of patients undergoing catheter ablation for symptomatic atrial fibrillation...
Long-term exposure to road traffic noise associated with higher risk of incident HF Dr. Shravani Dali16 July 2023 8:30 PM ISTLong-term exposure to road traffic noise is associated with a higher risk of incident HF suggests a new study published in the JACC: Heart...
